$NAVB NAVIDEA BIOPHARMACEUTICALS, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NAVIDEA BIOPHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NAVIDEA BIOPHARMACEUTICALS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in NAVIDEA BIOPHARMACEUTICALS, INC. for free.

CIK Number: 0000810509
IRS Number: 311080091
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Trading Symbol: NAVB
Company Address: 4995 BRADENTON AVENUE SUITE 240 DUBLIN 43017
Phone number: 6147937500
Former name: NEOPROBE CORP, date of change: 1994-07-14

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It is developing multiple precision-targeted products based on their manocept platform to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. The company operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.

Market Capitalization: $77.59M
Prev close: $0.52
Average Daily Volume: 833,077
Days Low: $0.49
Year Low: $0.26
Year High: $1.51

NAVIDEA BIOPHARMACEUTICALS, INC. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Bruck ClaudineDirector50,00026,000shares bought: 50,000 / shares sold: 0 BUYMar 16 20181 month ago
Cope Frederick OSVP & CSO372,662193,784shares bought: 224,072 / shares sold: 0 STRONG BUYFeb 22 20182 months ago
Greene Mark IDirector157,24481,767shares bought: 157,244 / shares sold: 0 STRONG BUYFeb 22 20182 months ago
RICE YEHUDA MICHAELDirector100,00052,000shares bought: 324,000 / shares sold: -28,000 STRONG BUYFeb 22 20182 months ago
Rowinsky Eric KDirector341,446177,552shares bought: 138,726 / shares sold: 0 STRONG BUYFeb 22 20182 months ago

View all NAVIDEA BIOPHARMACEUTICALS, INC. insiders.

NAVIDEA BIOPHARMACEUTICALS, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 16 2018NAVBNAVIDEA BIOPHARMAC ...Bruck ClaudineDirectorOption ExerciseA0.7550,00037,50050,000
Mar 16 2018NAVBNAVIDEA BIOPHARMAC ...Bruck ClaudineDirectorGrantA0.0050,0005050,0000 to 50 K
Feb 22 2018NAVBNAVIDEA BIOPHARMAC ...Rowinsky Eric KDirectorOption ExerciseA0.7550,00037,500173,764
Feb 22 2018NAVBNAVIDEA BIOPHARMAC ...Rowinsky Eric KDirectorGrantA0.0050,00050341,446291.4 K to 341.4 K (+17.16 %)
Feb 22 2018NAVBNAVIDEA BIOPHARMAC ...RICE YEHUDA MICHAELDirectorOption ExerciseA0.7550,00037,500100,000
Feb 22 2018NAVBNAVIDEA BIOPHARMAC ...RICE YEHUDA MICHAELDirectorGrantA0.0050,00050100,00050 K to 100 K (+100.00 %)
Feb 22 2018NAVBNAVIDEA BIOPHARMAC ...Greene Mark IDirectorOption ExerciseA0.7550,00037,500100,000
Feb 22 2018NAVBNAVIDEA BIOPHARMAC ...Greene Mark IDirectorGrantA0.0050,00050157,244107.2 K to 157.2 K (+46.62 %)
Feb 22 2018NAVBNAVIDEA BIOPHARMAC ...Cope Frederick OSVP & CSOGrantA0.36135,69448,850372,662237 K to 372.7 K (+57.26 %)
Sep 19 2017NAVBNAVIDEA BIOPHARMAC ...RICE YEHUDA MICHAELDirectorGiftG0.0028,000050,00078 K to 50 K (-35.90 %)
Jul 03 2017NAVBNAVIDEA BIOPHARMAC ...Regan William J.SVP & CCOBuyP0.5320,00010,586172,977153 K to 173 K (+13.07 %)
Jun 30 2017NAVBNAVIDEA BIOPHARMAC ...Rowinsky Eric KDirectorOption ExerciseA0.7550,00037,50050,000
Jun 30 2017NAVBNAVIDEA BIOPHARMAC ...Rowinsky Eric KDirectorGrantA0.0050,00050291,446241.4 K to 291.4 K (+20.71 %)
Jun 30 2017NAVBNAVIDEA BIOPHARMAC ...RICE YEHUDA MICHAELDirectorOption ExerciseA0.7550,00037,50050,000
Jun 30 2017NAVBNAVIDEA BIOPHARMAC ...RICE YEHUDA MICHAELDirectorGrantA0.0050,0005078,00028 K to 78 K (+178.57 %)

View all NAVIDEA BIOPHARMACEUTICALS, INC. insider transactions.